These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Autologous stem cell transplantation in multiple myeloma is not dead but alive and well. Martino M; Morabito F Expert Opin Biol Ther; 2015 Feb; 15(2):149-54. PubMed ID: 25435056 [TBL] [Abstract][Full Text] [Related]
7. Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era. Takamatsu H; Honda S; Miyamoto T; Yokoyama K; Hagiwara S; Ito T; Tomita N; Iida S; Iwasaki T; Sakamaki H; Suzuki R; Sunami K Cancer Sci; 2015 Feb; 106(2):179-85. PubMed ID: 25530023 [TBL] [Abstract][Full Text] [Related]
8. Autologous stem cell transplantation for multiple myeloma in the era of novel agents. Shimazaki C Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):14-5. PubMed ID: 24461805 [No Abstract] [Full Text] [Related]
9. The role of tandem stem cell transplantation for multiple myeloma patients. Martino M; Recchia AG; Fedele R; Neri S; Vincelli ID; Moscato T; Gentile M; Morabito F Expert Opin Biol Ther; 2016; 16(4):515-34. PubMed ID: 26698133 [TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of autologous transplantation for newly diagnosed multiple myeloma in the era of novel agents. Su B; Zhu X; Jiang Y; Wang L; Zhao N; Ran X; Zheng X; Guo H Leuk Lymphoma; 2019 Jun; 60(6):1381-1388. PubMed ID: 30516074 [TBL] [Abstract][Full Text] [Related]
11. High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future. Björkstrand B; Gahrton G Semin Hematol; 2007 Oct; 44(4):227-33. PubMed ID: 17961721 [TBL] [Abstract][Full Text] [Related]
12. [Bortezomib-based induction therapy followed by autologous hematopoietic stem cell transplantation in multiple myeloma]. Huang B; Li J; Liu J; Gu J; Zheng D; Xu D; Zou W; Wang H Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):865-72. PubMed ID: 25586356 [TBL] [Abstract][Full Text] [Related]
13. The future of autologous stem cell transplantation in myeloma. van Rhee F; Giralt S; Barlogie B Blood; 2014 Jul; 124(3):328-33. PubMed ID: 24894774 [TBL] [Abstract][Full Text] [Related]
14. Role of stem cell transplantation. Harousseau JL Hematol Oncol Clin North Am; 2007 Dec; 21(6):1157-74, x. PubMed ID: 17996593 [TBL] [Abstract][Full Text] [Related]
15. BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. Veeraputhiran M; Jain T; Deol A; Ayash L; Kim S; Dyson G; Bhutani D; Lum LG; Ratanatharathorn V; Uberti JP; Abidi MH Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):531-5. PubMed ID: 26166312 [TBL] [Abstract][Full Text] [Related]
16. Role of hematopoietic stem cell transplantation in multiple myeloma. Garcia IN Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):86-91. PubMed ID: 25131852 [TBL] [Abstract][Full Text] [Related]
17. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma. Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040 [TBL] [Abstract][Full Text] [Related]
18. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506 [TBL] [Abstract][Full Text] [Related]
20. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy. Kyle RA Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]